Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Research & Development (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Research & Development data on record, last reported at $10.9 million in Q4 2025.

  • For Q4 2025, Research & Development rose 2.49% year-over-year to $10.9 million; the TTM value through Dec 2025 reached $44.7 million, up 38.3%, while the annual FY2025 figure was $44.7 million, 38.3% up from the prior year.
  • Research & Development reached $10.9 million in Q4 2025 per PLSE's latest filing, down from $11.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $12.1 million in Q2 2025 and bottomed at $300000.0 in Q1 2021.
  • Average Research & Development over 5 years is $7.3 million, with a median of $7.0 million recorded in 2022.
  • Peak YoY movement for Research & Development: tumbled 95.15% in 2021, then skyrocketed 2156.33% in 2022.
  • A 5-year view of Research & Development shows it stood at $5.7 million in 2021, then dropped by 27.62% to $4.1 million in 2022, then surged by 90.45% to $7.8 million in 2023, then surged by 36.71% to $10.7 million in 2024, then grew by 2.49% to $10.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $10.9 million in Q4 2025, $11.4 million in Q3 2025, and $12.1 million in Q2 2025.